Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction

Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction

Background: Breast cancer is the most common malignancy in women. Clinical models such as Oncotype DX recurrence score (RS) and Clinical Treatment Score post–5 years (CTS5) model for survival prediction are crucial for clinical practice. However, it remains unclear whether CTS5 or RS would be a more...

Full description

Bibliographic Details
Main Authors: Changjun Wang, Ying Xu, Yan Lin, Yidong Zhou, Feng Mao, Xiaohui Zhang, Songjie Shen, Yanna Zhang, Qiang Sun
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Breast
Subjects:
Breast cancer
Oncotype
Recurrence score
Clinical treatment score post–5 years
Clinical risk model
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977622000571

Similar Items

Similar Items